Unveiling KKR & Co. (KKR) Q1 Outlook: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of KKR & Co. (KKR) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
KKR Q1 Preview: A Solid Business, But Sentiment Needs To Catch Up
KKR & Co. Inc. is set to report Q1 results on May 1, with low expectations but the potential for a positive surprise, especially after a strong last quarter. The $1.2 billion acquisition of Biotage signals KKR's strategic expansion in life sciences, reinforcing confidence in long-term value despite market challenges. Despite a high valuation and recent stock underperformance, KKR's fundamentals remain strong, with robust cash generation, fundraising momentum, and growing assets under management.
KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage
The deal values the Swedish company at $1.2 billion, and the Biotage board recommended that shareholders accept the offer.
FS KKR Capital: Buy The Tariff Tantrum, Secure A 13.7% Yield
FS KKR Capital's stock is undervalued, trading at a 21% discount to NAV, presenting a compelling buying opportunity despite higher-than-average non-accruals and declining net investment income. The BDC's credit profile has improved compared to 2023, and it could suspend its supplemental dividend to maintain its base dividend. FS KKR Capital's net investment income fell in 4Q24 due to higher loan repayments, leading to a higher dividend pay-out ratio and potential short-term dividend coverage challenges.
FS KKR Capital: How Good Is This 15% Yield?
FS KKR Capital offers a high dividend yield of 15%, with shares trading at an inexpensive valuation, making it an attractive entry point. Despite a 12% decline in net investment income per share, the yield on debt investments remains high, stabilizing with current interest rates. The portfolio has become more diversified, but the non-accrual rate has risen to 2.2%, indicating potential risks.
KKR's "White Knight" Strategy in Buying Assets
Henry McVey, KKR's Head of Global Macro and Asset Allocation joined Wall Street Beat on Bloomberg Open Interest to talk about KKR's activism strategy. -------- More on Bloomberg Television and Markets Like this video?
Buyout firm KKR to buy OSTTRA in $3.1 billion deal
Private equity firm KKR will buy post-trade services company OSTTRA in a $3.1 billion deal, S&P Global and CME Group announced on Monday.
Primary Health Properties makes counter bid for Assura, below KKR offer
Primary Health Properties PLC (LSE:PHP, OTC:PHPRF) has launched a rival bid for Assura Group (LSE:AGR), which has already backed a possible offer from a US consortium made up of KKR and Stonepeak Partners. Intriguinly, PHP has not looked to beat the KKR-led £1.6 billion offer for its fellow healthcare property peer, which was priced at 49.4p per share.
KKR partner says fund is analysing FiberCop-Open Fiber tie-up
U.S. fund KKR , the main shareholder in Italian fibre optic grid operator FiberCop, is analysing a possible tie-up with Italy's Open Fiber as part of a broader government plan to create a single broadband network, KKR Partner Alberto Signori said at conference in Milan on Tuesday.
Thames Water in talks with US investment giant KKR to be new majority owner
Thames Water Utilities has chosen KKR as its "preferred partner", moving into a new stage of talks where the US private equity giant could buy a majority stake. The UK's largest water company said it hoped to agree terms for a share sale by the end of June, enabling it to raise rescue funds by the end of the year.
Thames Water Chooses KKR as Preferred Partner for Recapitalization
The debt-laden water utility selected U.S. private equity company KKR as its preferred partner to lead its recapitalization.
KKR nears deal to buy Japanese medical gear maker Topcon, sources say
Private equity firm KKR is nearing a deal to acquire Japanese medical gear maker Topcon , according to people familiar with the matter, marking the latest sign of increased leveraged buyout activity in Japan.
